Paper18596154
Immunotherapy reduces vascular amyloid-beta in PDAPP mice.
Schroeter S and 10 others. J Neurosci, 2008. Cited by 115 papers, by iCite.
Cite this record
ConductScience Library. Immunotherapy reduces vascular amyloid-beta in PDAPP mice. Papers, record 18596154. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18596154
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amyloid beta-Peptides | Major topic |
| Cerebral Amyloid Angiopathy | Major topic |
| Cerebral Hemorrhage | Major topic |
| Immunization, Passive | Major topic |
| Amyloid beta-Protein Precursor | |
| Animals | |
| Antibodies | |
| Cerebral Arteries | |
| Disease Models, Animal | |
| Dose-Response Relationship, Drug | |
| Down-Regulation | |
| Epitopes | |
| Female | |
| Metabolic Clearance Rate | |
| Mice | |
| Mice, Transgenic | |
| Treatment Outcome |
Source PubMed
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10408445 | Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. | Nature | 1999 | https://conductscience.org/library/papers/10408445 | PubMed |
| 2 | 1406936 | Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. | Nature | 1992 | https://conductscience.org/library/papers/1406936 | PubMed |
| 3 | 9037091 | Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease. | Proc Natl Acad Sci U S A | 1997 | https://conductscience.org/library/papers/9037091 | PubMed |
| 4 | 12765607 | Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease. | Neuron | 2003 | https://conductscience.org/library/papers/12765607 | PubMed |
| 5 | 12566568 | Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's disease-like neuropathology. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/12566568 | PubMed |
| 6 | 17314293 | Antibody-mediated clearance of amyloid-beta peptide from cerebral amyloid angiopathy revealed by quantitative in vivo imaging. | J Neurosci | 2007 | https://conductscience.org/library/papers/17314293 | PubMed |
| 7 | 15459438 | Amyloid angiopathy-related vascular cognitive impairment. | Stroke | 2004 | https://conductscience.org/library/papers/15459438 | PubMed |
| 8 | 15642916 | Abeta vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease. | Neurology | 2005 | https://conductscience.org/library/papers/15642916 | PubMed |
| 9 | 11140685 | A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. | Nature | 2000 | https://conductscience.org/library/papers/11140685 | PubMed |
| 10 | 16936277 | Amyloid-beta peptide remnants in AN-1792-immunized Alzheimer's disease patients: a biochemical analysis. | Am J Pathol | 2006 | https://conductscience.org/library/papers/16936277 | PubMed |
| 11 | 15588287 | Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage. | J Neuroinflammation | 2004 | https://conductscience.org/library/papers/15588287 | PubMed |
| 12 | 16914852 | Mice as models: transgenic approaches and Alzheimer's disease. | J Alzheimers Dis | 2006 | https://conductscience.org/library/papers/16914852 | PubMed |
| 13 | 12662319 | Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid beta from the human brain. | Neuropathol Appl Neurobiol | 2003 | https://conductscience.org/library/papers/12662319 | PubMed |
| 14 | 15052274 | Transgenic animal models of Alzheimer's disease and related disorders: histopathology, behavior and therapy. | Mol Psychiatry | 2004 | https://conductscience.org/library/papers/15052274 | PubMed |
| 15 | 10932230 | Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. | Nat Med | 2000 | https://conductscience.org/library/papers/10932230 | PubMed |
| 16 | 12640446 | Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. | Nat Med | 2003 | https://conductscience.org/library/papers/12640446 | PubMed |
| 17 | 11140686 | A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. | Nature | 2000 | https://conductscience.org/library/papers/11140686 | PubMed |
| 18 | 16707786 | Deglycosylated anti-amyloid-beta antibodies eliminate cognitive deficits and reduce parenchymal amyloid with minimal vascular consequences in aged amyloid precursor protein transgenic mice. | J Neurosci | 2006 | https://conductscience.org/library/papers/16707786 | PubMed |
| 19 | 16207868 | Beta-amyloid immunotherapy prevents synaptic degeneration in a mouse model of Alzheimer's disease. | J Neurosci | 2005 | https://conductscience.org/library/papers/16207868 | PubMed |
| 20 | 8649554 | Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV. | Neurology | 1996 | https://conductscience.org/library/papers/8649554 | PubMed |
Cited by68
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 115 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42363270 | Early binding of anti-amyloid antibodies to CAA drives complement activation, inflammation and ARIA in mice. | Mol Neurodegener | 2026 | https://conductscience.org/library/papers/42363270 | PubMed |
| 42015334 | Amyloid-related imaging abnormalities (ARIA) in anti-amyloid therapies for Alzheimer's disease: An update from the Alzheimer's Association ARIA workgroup. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/42015334 | PubMed |
| 41867862 | Early Binding of Anti-Amyloid Antibodies to CAA Drives Complement Activation, Inflammation and ARIA in Mice. | bioRxiv | 2026 | https://conductscience.org/library/papers/41867862 | PubMed |
| 40361247 | Mouse models of Anti-Aβ immunotherapies. | Mol Neurodegener | 2025 | https://conductscience.org/library/papers/40361247 | PubMed |
| 39897432 | Enhancing Antibody Exposure in the Central Nervous System: Mechanisms of Uptake, Clearance, and Strategies for Improved Brain Delivery. | J Nanotheranostics | 2023 | https://conductscience.org/library/papers/39897432 | PubMed |
| 39794509 | Amyloid-related imaging abnormalities: manifestations, metrics and mechanisms. | Nat Rev Neurol | 2025 | https://conductscience.org/library/papers/39794509 | PubMed |
| 38891941 | Temporal Characterization of the Amyloidogenic APPswe/PS1dE9;hAPOE4 Mouse Model of Alzheimer's Disease. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38891941 | PubMed |
| 38225272 | Amyloid beta 42 alters cardiac metabolism and impairs cardiac function in male mice with obesity. | Nat Commun | 2024 | https://conductscience.org/library/papers/38225272 | PubMed |
| 37649100 | Amyloid-β (Aβ) immunotherapy induced microhemorrhages are associated with activated perivascular macrophages and peripheral monocyte recruitment in Alzheimer's disease mice. | Mol Neurodegener | 2023 | https://conductscience.org/library/papers/37649100 | PubMed |
| 36500385 | Neuroprotective Effects of the Psychoactive Compound Biatractylolide (BD) in Alzheimer's Disease. | Molecules | 2022 | https://conductscience.org/library/papers/36500385 | PubMed |
| 35340615 | Structural biology of cell surface receptors implicated in Alzheimer's disease. | Biophys Rev | 2022 | https://conductscience.org/library/papers/35340615 | PubMed |
| 35108575 | Blood-brain barrier leakage in Alzheimer's disease: From discovery to clinical relevance. | Pharmacol Ther | 2022 | https://conductscience.org/library/papers/35108575 | PubMed |
| 33969279 | Carbon Quantum Dots for Treatment of Amyloid Disorders. | ACS Appl Nano Mater | 2021 | https://conductscience.org/library/papers/33969279 | PubMed |
| 32927795 | Both Amyloid-β Peptide and Tau Protein Are Affected by an Anti-Amyloid-β Antibody Fragment in Elderly 3xTg-AD Mice. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32927795 | PubMed |
| 31157360 | Persistent neuropathological effects 14 years following amyloid-β immunization in Alzheimer's disease. | Brain | 2019 | https://conductscience.org/library/papers/31157360 | PubMed |
| 29163036 | Amino-Terminal β-Amyloid Antibody Blocks β-Amyloid-Mediated Inhibition of the High-Affinity Choline Transporter CHT. | Front Mol Neurosci | 2017 | https://conductscience.org/library/papers/29163036 | PubMed |
| 28800329 | Chronic Verubecestat Treatment Suppresses Amyloid Accumulation in Advanced Aged Tg2576-AβPPswe Mice Without Inducing Microhemorrhage. | J Alzheimers Dis | 2017 | https://conductscience.org/library/papers/28800329 | PubMed |
| 28143566 | APOE Genotype Differentially Modulates Effects of Anti-Aβ, Passive Immunization in APP Transgenic Mice. | Mol Neurodegener | 2017 | https://conductscience.org/library/papers/28143566 | PubMed |
| 27239538 | Amyloid-related imaging abnormalities from trials of solanezumab for Alzheimer's disease. | Alzheimers Dement (Amst) | 2016 | https://conductscience.org/library/papers/27239538 | PubMed |
| 26551546 | Decreased amyloid-β and increased neuronal hyperactivity by immunotherapy in Alzheimer's models. | Nat Neurosci | 2015 | https://conductscience.org/library/papers/26551546 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| APP | 351 | PubTator's text mining | https://conductscience.org/library/genes/351 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/18596154
GET https://conductscience.org/api/papers/v1/18596154/references?page=2